Wedbush Securities released a report on Curaleaf Holdings, Inc. (OTC: CURLF), the largest U.S. cannabis company by market cap, raising the stock's 12-month price target to $7.00 from $6.00 and maintaining a buy recommendation (Outperform rating).
Key Financials And Rating
Curaleaf's market cap stands at $4.12 billion with an enterprise value of $4.60 billion. The company reported Q1 2024 revenue of $338.9 million, aligning with expectations, and a sequential improvement in gross margin.
The projected revenue for 2024 is $1.40 billion, with adjusted EBITDA expected to be $339 million, according to the report, authored by analysts Gerald Pascarelli and Antoine Legault.
Domestic And International Expansion
Curaleaf continues to benefit from strong performance in key domestic markets such as Connecticut, Arizona, Maryland and New York. The report highlights upcoming catalysts, including the adult-use rollout in Ohio and potential expansion in